Studies have confirmed that patients with PAH of various causes have significantly higher levels of cytokines in their plasma compared with control groups, including IL-2, IL-6, IL-8, and IL-10, which have been shown to significantly impact patient survival and can serve as useful biomarkers for assessing the risk of developing PAH [11]. The gene discussed is IL10; the disease is pulmonary arterial hypertension.